Menopausal hormone therapy use beyond 65 years beneficial
Apr 16, 2024
Use of menopausal hormone therapy beyond age 65 years is associated with risk reductions in mortality as well as specific cancers and cardiovascular diseases, according to a study published online April...
Decline seen in patients undergoing surgery for colon, rectal cancer in 2020
Apr 11, 2024
Patients undergoing surgery in 2020 versus 2019 had a more advanced clinical and pathological tumor stage.
AACR: Accelerated aging linked to incidence of early-onset cancer
Apr 09, 2024
Accelerated aging was associated with an increased risk for early-onset tumors, driven by lung, gastrointestinal and uterine cancers.
Up to 30 percent of CVD mortality attributable to excess salt intake
Mar 29, 2024
The population-attributable risk estimates suggest that sodium above the recommended intake is linked to 10 to 30% of CVD mortality.
Calcium, vitamin D supplements may reduce cancer mortality in long term
Mar 11, 2024
But an increase in cardiovascular disease mortality was seen after more than 20 years of follow-up among older women.
Light and sound therapy may fend off memory and cognitive damage for chemo patients
By
Aaron Dorman
Mar 08, 2024
A combination of light and sound therapy may be able to counteract the problems in the brain caused by chemo, new research shows.
Heart attack survivorship tied to long-term health consequences
Mar 04, 2024
An increased risk was seen for atrial fibrillation and cerebrovascular disease, among others.
In trial, researchers test EHR alerts to lower harmful screenings, overtreatment in seniors
By
Kristen Fischer
Feb 15, 2024
Researchers devised a new way to ensure that older adults aren’t being overtreated or tested needlessly via unnecessary screenings.
Cutting social isolation, loneliness may lower mortality in people with obesity
Jan 24, 2024
The authors say that the findings support efforts to improve social isolation and loneliness.
Most men choose active surveillance for low-risk prostate cancer
Jan 22, 2024
Older age, white race, and higher education were patient factors associated with initial active surveillance uptake in an unadjusted analysis.